Target
Insulin-degrading enzyme
Ligand
BDBM50427702
Substrate
n/a
Meas. Tech.
ChEMBL_941899 (CHEMBL2329965)
Ki
103±n/a nM
Citation
 Abdul-Hay, SOLane, ALCaulfield, TRClaussin, CBertrand, JMasson, AChoudhry, SFauq, AHMaharvi, GMLeissring, MA Optimization of peptide hydroxamate inhibitors of insulin-degrading enzyme reveals marked substrate-selectivity. J Med Chem 56:2246-55 (2013) [PubMed]  Article 
Target
Name:
Insulin-degrading enzyme
Synonyms:
Abeta-degrading protease | Human Insulin Degrading Enzyme (hIDE) | IDE | IDE_HUMAN | Insulin degrading enzyme (hIDE) | Insulin protease | Insulin-degrading enzyme | Insulinase | Insulysin | insulin-degrading enzyme isoform 1 precursor
Type:
Enzyme Catalytic Domain
Mol. Mass.:
117968.59
Organism:
Homo sapiens (Human)
Description:
P14735
Residue:
1019
Sequence:
MRYRLAWLLHPALPSTFRSVLGARLPPPERLCGFQKKTYSKMNNPAIKRIGNHITKSPEDKREYRGLELANGIKVLLISDPTTDKSSAALDVHIGSLSDPPNIAGLSHFCEHMLFLGTKKYPKENEYSQFLSEHAGSSNAFTSGEHTNYYFDVSHEHLEGALDRFAQFFLCPLFDESCKDREVNAVDSEHEKNVMNDAWRLFQLEKATGNPKHPFSKFGTGNKYTLETRPNQEGIDVRQELLKFHSAYYSSNLMAVCVLGRESLDDLTNLVVKLFSEVENKNVPLPEFPEHPFQEEHLKQLYKIVPIKDIRNLYVTFPIPDLQKYYKSNPGHYLGHLIGHEGPGSLLSELKSKGWVNTLVGGQKEGARGFMFFIINVDLTEEGLLHVEDIILHMFQYIQKLRAEGPQEWVFQECKDLNAVAFRFKDKERPRGYTSKIAGILHYYPLEEVLTAEYLLEEFRPDLIEMVLDKLRPENVRVAIVSKSFEGKTDRTEEWYGTQYKQEAIPDEVIKKWQNADLNGKFKLPTKNEFIPTNFEILPLEKEATPYPALIKDTAMSKLWFKQDDKFFLPKACLNFEFFSPFAYVDPLHCNMAYLYLELLKDSLNEYAYAAELAGLSYDLQNTIYGMYLSVKGYNDKQPILLKKIIEKMATFEIDEKRFEIIKEAYMRSLNNFRAEQPHQHAMYYLRLLMTEVAWTKDELKEALDDVTLPRLKAFIPQLLSRLHIEALLHGNITKQAALGIMQMVEDTLIEHAHTKPLLPSQLVRYREVQLPDRGWFVYQQRNEVHNNCGIEIYYQTDMQSTSENMFLELFCQIISEPCFNTLRTKEQLGYIVFSGPRRANGIQGLRFIIQSEKPPHYLESRVEAFLITMEKSIEDMTEEAFQKHIQALAIRRLDKPKKLSAECAKYWGEIISQQYNFDRDNTEVAYLKTLTKEDIIKFYKEMLAVDAPRRHKVSVHVLAREMDSCPVVGEFPCQNDINLSQAPALPQPEVIQNMTEFKRGLPLFPLVKPHINFMAAKL
  
Inhibitor
Name:
BDBM50427702
Synonyms:
CHEMBL2324202
Type:
Small organic molecule
Emp. Form.:
C37H45N9O9
Mol. Mass.:
759.8081
SMILES:
NC(N)=NCCC[C@H](NC(=O)[C@H](Cc1ccc2ccccc2c1)[C@@H](O)C(=O)NO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(O)=O)C(N)=O |r,wU:7.7,46.49,11.10,23.25,wD:32.33,(39.49,-27.52,;40.85,-28.23,;42.15,-27.4,;40.92,-29.77,;39.62,-30.59,;39.69,-32.13,;38.39,-32.96,;38.47,-34.5,;37.17,-35.33,;35.84,-34.56,;35.84,-33.02,;34.5,-35.33,;33.2,-34.56,;33.17,-33.02,;31.81,-32.27,;31.78,-30.73,;33.1,-29.93,;33.07,-28.39,;34.38,-27.6,;35.74,-28.33,;35.78,-29.87,;34.45,-30.68,;34.49,-32.22,;34.5,-36.87,;35.83,-37.64,;33.17,-37.64,;31.83,-36.87,;33.17,-39.18,;31.83,-39.96,;39.83,-35.2,;39.89,-36.74,;41.13,-34.38,;42.49,-35.09,;42.56,-36.63,;43.93,-37.33,;45.38,-36.83,;46.31,-38.06,;45.43,-39.32,;45.77,-40.82,;44.65,-41.87,;43.18,-41.42,;42.83,-39.92,;43.96,-38.87,;43.79,-34.26,;43.72,-32.72,;45.15,-34.97,;46.45,-34.14,;46.39,-32.6,;47.68,-31.78,;47.61,-30.24,;46.25,-29.52,;48.91,-29.41,;47.81,-34.85,;49.11,-34.02,;47.89,-36.39,)|
Structure:
Search PDB for entries with ligand similarity: